{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04022",
      "entity_text" : "pH3T6",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "uaz:UA-CLine-5317" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "The choice of kinase inhibitors targeting the kinases implicated into the presence of high levels of pH3T6, pH3S10 or pH3Y41 in PCTC-GBM fell on Enzastaurin (a PKCbeta inhibitor), AZD1152 (an Aurora-B inhibitor) and AZD1480 (a Jak2 inhibitor) since these drugs target kinases implicated into the presence of presence of high levels of pH3T6, pH3S10 or pH3Y41 in GBM, and that these drugs are used in clinical (source : www.clinicaltrilas.gov) XREF_BIBR - XREF_BIBR.",
  "reading_complete" : "2020-08-03T13:57:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:56:08Z",
  "trigger" : "levels",
  "evidence" : [ "levels of pH3T6" ],
  "pmc_id" : "4265745",
  "score" : 0
}